{"schema_version":"1","generated_at":"2026-10-28T08:27:02.665Z","data_as_of":"2026-10-26","url":"https://www.findmykol.com/kol/steve-braunstein","json_url":"https://www.findmykol.com/kol/steve-braunstein/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"steve-braunstein","name":"Steve Braunstein","credential":"MD","title":"Associate Professor and Vice Chair, Department of Radiation Oncology","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Neuro-Oncology","therapeutic_areas":["Neuro-Oncology"],"institution":"University of California, San Francisco (UCSF)","institution_url":"https://www.findmykol.com/institution/university-of-california-san-francisco","city":"San Francisco","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1760610141","orcid":"0000-0002-9841-9357","openalex":"A5072259049"},"summary":"Steve Braunstein is Associate Professor and Vice Chair, Department of Radiation Oncology at University of California, San Francisco (UCSF). OpenAlex indexes 527 publications with 10,221 citations (h-index 52); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.","overview":{"text":"Steve Braunstein, MD, PHD, is Associate Professor and Vice Chair, Department of Radiation Oncology at University of California, San Francisco (UCSF). The public record shows 527 publications with 10,221 citations (h-index 52), centered on Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Management of metastatic bone disease. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 6 companies, 1 NIH-funded awards (2025–2026).","bullets":["Most recent indexed publication: 2026 · Neuro-oncology practice","Top research focus: Glioma Diagnosis and Treatment","5 registered trials on ClinicalTrials.gov","Open Payments reporting from 6 companies"],"generated_at":"2026-10-27"},"focus":{"indications":[{"label":"Meningioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neoplasm Metastasis","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Carcinoma, Small Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":0,"topics":1,"strength":1}],"research_topics":["Glioma Diagnosis and Treatment","Brain Metastases and Treatment","Management of metastatic bone disease","Advanced Radiotherapy Techniques","Meningioma and schwannoma management"],"works_with":{"total":10,"shown":3,"withheld":7,"rows":[{"name":"icotec Medical Inc.","trials":0,"payments":33,"mentions":33},{"name":"Novocure Inc.","trials":0,"payments":14,"mentions":14},{"name":"GT Medical Technologies, Inc","trials":0,"payments":8,"mentions":8}]}},"scholarship":{"works_count":527,"cited_by_count":10221,"h_index":52,"i10_index":144,"pubmed_count":18,"latest_activity_year":2026,"source":"works"},"trials":{"count":5,"shown":3,"withheld":2,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07346170","title":"Short Interval Postoperative Stereotactic Body Radiation Therapy (SBRT) After Surgical Intervention for Spine Metastases","phase":"NA","status":"NOT_YET_RECRUITING","role":"Investigator","sponsor":"University of California, San Francisco","source_url":"https://clinicaltrials.gov/study/NCT07346170","trial_url":"https://www.findmykol.com/trial/NCT07346170"},{"nct":"NCT06518057","title":"Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"University of Washington","source_url":"https://clinicaltrials.gov/study/NCT06518057","trial_url":"https://www.findmykol.com/trial/NCT06518057"},{"nct":"NCT04659811","title":"Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Investigator","sponsor":"Nancy Ann Oberheim Bush, MD","source_url":"https://clinicaltrials.gov/study/NCT04659811","trial_url":"https://www.findmykol.com/trial/NCT04659811"}],"source":"trials"},"payments":{"company_count":6,"program_years":{"first":2021,"last":2025},"rows_total":11,"shown":3,"withheld":8,"rows":[{"payer":"Novocure Inc.","program_year":2025,"amount_usd":6323.81,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1760610141"},{"payer":"GT Medical Technologies, Inc","program_year":2025,"amount_usd":1768,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1760610141"},{"payer":"icotec Medical Inc.","program_year":2025,"amount_usd":1032.13,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1760610141"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1760610141","source":"payments"},"prescribing":{"data_year":2020,"areas_total":1,"areas_shown":1,"areas":[{"area":"Sensory organs","share_pct":100,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":100,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":11}]}],"care_setting":{"dominant":"facility","data_year":2020,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2025,"last":2026},"rows_total":2,"shown":2,"withheld":0,"rows":[{"project":"R01CA292043","title":"Development of a Personalized Voxel-wise Prediction of Brain Metastases using Multi-Parametric MR Imaging to Reduce Treatment Toxicity","fiscal_year":2026,"amount_usd":713733,"organization":"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","source_url":"https://reporter.nih.gov/quickSearch/R01CA292043"},{"project":"R01CA292043","title":"Development of a Personalized Voxel-wise Prediction of Brain Metastases using Multi-Parametric MR Imaging to Reduce Treatment Toxicity","fiscal_year":2025,"amount_usd":729587,"organization":"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","source_url":"https://reporter.nih.gov/quickSearch/R01CA292043"}],"source":"grants"},"congress":{"count":135,"years":{"first":2004,"last":2026},"societies":["AACR","ASCO","ASH","ASTRO"],"shown":3,"withheld":132,"rows":[{"title":"Impact of genomic subtype on intracranial outcomes in treatment-naive EGFR -mutant NSCLC with osimertinib (IGnITE).","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.2020","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.2020","status":"verified"},{"title":"A Phase III Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Lorlatinib Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (ANBL1531)","society":"ASTRO","meeting":"ASTRO Annual Meeting","year":2026,"role":"presenting_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.ijrobp.2026.06.982","source_url":"https://doi.org/10.1016/j.ijrobp.2026.06.982","status":"verified"},{"title":"Alteration Subtype is Prognostic of Intracranial Outcome and Predicts the Benefit of Upfront SRS in EGFR-Mutant NSCLC Brain Metastasis","society":"ASTRO","meeting":"ASTRO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.ijrobp.2026.06.189","source_url":"https://doi.org/10.1016/j.ijrobp.2026.06.189","status":"verified"}],"source":"congress"},"publications":{"total":18,"shown":5,"withheld":13,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"A multidisciplinary program for meningioma treatment, research, and support services.","year":2026,"journal":"Neuro-oncology practice","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42750788/","status":"verified"},{"title":"Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma.","year":2026,"journal":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","types":["Journal Article","Clinical Trial, Phase II"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42202246/","status":"verified"},{"title":"Natural language processing to identify documented pain preceding radiation therapy for bone metastases.","year":2026,"journal":"JNCI cancer spectrum","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41639010/","status":"verified"},{"title":"Characterization of Clinical Outcomes for Patients with Relapsed High-Risk Neuroblastoma After Autologous Stem Cell Transplant and External Beam Radiotherapy.","year":2026,"journal":"Cancers","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41681992/","status":"verified"},{"title":"Unsupervised Large Language Models to Identify Topics in Cancer Center Patient Portal Messages.","year":2025,"journal":"JCO clinical cancer informatics","types":["Journal Article","Research Support, N.I.H., Extramural"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41032743/","status":"verified"}],"most_cited":{"total":527,"shown":5,"withheld":522,"rows":[{"title":"Radiation-Induced CXCL16 Release by Breast Cancer Cells Attracts Effector T Cells","year":2008,"cited_by_count":711,"type":"article","source_url":"https://doi.org/10.4049/jimmunol.181.5.3099"},{"title":"Estimating Survival in Patients With Lung Cancer and Brain Metastases","year":2016,"cited_by_count":662,"type":"article","source_url":"https://doi.org/10.1001/jamaoncol.2016.3834"},{"title":"Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient","year":2020,"cited_by_count":476,"type":"article","source_url":"https://doi.org/10.1200/jco.20.01255"},{"title":"A Hypoxia-Controlled Cap-Dependent to Cap-Independent Translation Switch in Breast Cancer","year":2007,"cited_by_count":309,"type":"article","source_url":"https://doi.org/10.1016/j.molcel.2007.10.019"},{"title":"Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities","year":2022,"cited_by_count":295,"type":"article","source_url":"https://doi.org/10.1038/s41588-022-01061-8"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"David Ronan Raleigh","coauthored_works":119},{"name":"Penny K. Sneed","coauthored_works":94},{"name":"Jean L. Nakamura","coauthored_works":78}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/steve-braunstein-md","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":1,"shown":1,"rows":[{"value":"MD, PhD (New York University School of Medicine, 2009)","source_url":"https://profiles.ucsf.edu/steve.braunstein","status":"verified","collected_at":"2026-10-26"}]},"roles":{"total":4,"shown":3,"rows":[{"value":"Core leadership committee member, NRG","source_url":"https://radonc.ucsf.edu/steve-braunstein","status":"verified","collected_at":"2026-10-26"},{"value":"Core leadership committee member, COG","source_url":"https://radonc.ucsf.edu/steve-braunstein","status":"verified","collected_at":"2026-10-26"},{"value":"Vice-President, ADROP executive committee (ASTRO)","source_url":"https://www.astro.org/interest-groups/adrop/executive-committee/steve-braunstein","status":"provisional","collected_at":"2026-10-26"}]},"awards":{"total":3,"shown":3,"rows":[{"value":"Exceptional Physician Award, UCSF (2013)","source_url":"https://profiles.ucsf.edu/steve.braunstein","status":"verified","collected_at":"2026-10-26"},{"value":"AOA Inductee (2008)","source_url":"https://radonc.ucsf.edu/steve-braunstein","status":"verified","collected_at":"2026-10-26"},{"value":"Phi Beta Kappa Inductee (1997)","source_url":"https://radonc.ucsf.edu/steve-braunstein","status":"verified","collected_at":"2026-10-26"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"UCSF Brain Tumor Center, Pediatric Malignancies Program, and Sarcoma Program (member)","source_url":"https://radonc.ucsf.edu/steve-braunstein","status":"verified","collected_at":"2026-10-26"}]}},"similar":[{"name":"Bruce Miller","slug":"bruce-miller","institution":"University of California, San Francisco (UCSF)","specialty":"Neurology","url":"https://www.findmykol.com/kol/bruce-miller","json_url":"https://www.findmykol.com/kol/bruce-miller/profile.json"},{"name":"Gregory Marcus","slug":"gregory-marcus","institution":"University of California, San Francisco (UCSF)","specialty":"Clinical Cardiac Electrophysiology","url":"https://www.findmykol.com/kol/gregory-marcus","json_url":"https://www.findmykol.com/kol/gregory-marcus/profile.json"},{"name":"Eric Small","slug":"eric-small","institution":"University of California, San Francisco (UCSF)","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/eric-small","json_url":"https://www.findmykol.com/kol/eric-small/profile.json"},{"name":"Adam Boxer","slug":"adam-boxer","institution":"University of California, San Francisco (UCSF)","specialty":"Neurology","url":"https://www.findmykol.com/kol/adam-boxer","json_url":"https://www.findmykol.com/kol/adam-boxer/profile.json"},{"name":"Guy McKhann","slug":"guy-mckhann","institution":"Emory University School of Medicine","specialty":"Neurological Surgery","url":"https://www.findmykol.com/kol/guy-mckhann","json_url":"https://www.findmykol.com/kol/guy-mckhann/profile.json"},{"name":"Patrick Wen","slug":"patrick-wen","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/patrick-wen","json_url":"https://www.findmykol.com/kol/patrick-wen/profile.json"},{"name":"Minesh Mehta","slug":"minesh-mehta","institution":"Florida International University Herbert Wertheim College of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/minesh-mehta","json_url":"https://www.findmykol.com/kol/minesh-mehta/profile.json"},{"name":"Timothy Cloughesy","slug":"timothy-cloughesy","institution":"Ronald Reagan UCLA Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/timothy-cloughesy","json_url":"https://www.findmykol.com/kol/timothy-cloughesy/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":2,"payments":8,"congress":132,"publications":13,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-26"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-26"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-10-26"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2020},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-10-26"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-26"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-26"}},"methodology_url":"https://www.findmykol.com/about#methodology"}